Stephanie Kaasa

Dilworth, MN – Clinical and bioanalytical studies supporting pharmacology projects and multi-site patient trials continue at AXIS. Various projects supporting research to address the Coronavirus pandemic and other critical research for oncology, neurology, women’s health, and other key therapeutic areas are ongoing.

We have placed critical polices for safety and sanitization protocols for staff and participants. Daily reviews are being undertaken to ensure that our facilities and overall operations continue to be a clean and safe environment for all. We believe these steps will be appropriate and allow healthy volunteer studies with in-house stays to be conducted safely as well as overseeing clinical trials given the current SARS-Cov2 outbreak restrictions.

Dilworth, MN – Axis Clinicals USA announces they have received ERT Certification. The Certification program ensures sites are proficient in collecting the highest quality ECG data. This is done by conducting Phase I QT assessments using ERT’s proprietary Expert Precision QT approach.

With Axis Clinicals being ERT certified, we are able to work with biopharmaceutical clients making recommendations on the design, conduct, analysis, and interpretation of continuous Holter recordings to assess the cardiac safety profile of a drug during various pharmacology studies. AXIS’ encompassing clinical and bioanalytical operations at our purposed built facility in Dilworth, Minnesota allows expedited results with bioanalysis samples walked to an adjacent laboratory to the clinic, ideal for First-In-Human, Single Ascending Dose/Multiple Ascending Dose and Cardiac Safety pharmacology studies conducted at any time of a drug developments’ program.

About AXIS Clinicals USA
Our Dilworth, Minnesota (Fargo, ND area) Clinical/bioanalytical operations is centrally located in the US with a proven history of enrolling large panels of compliant healthy volunteers and targeted patient populations for complex studies.

For more information
John Pottier – Vice President, Business Development
j.pottier@axisclinicals.com

Dilworth, MN- AXIS Clinicals is pleased to announce the hire of Michael S. Willett, PharmD, RAC as the newest Senior Advisor for our clinical and scientific affairs team. Dr. Willett provides senior scientific input into the design and execution of early phase clinical trials. Dr. Willett has over 30 years of experience in clinical research and started his career at Marion Laboratories and Bristol-Myers Squibb where he was involved in all phases of cardiovascular and metabolic clinical research and multiple key product launches. Later he moved to the contract research organization (CRO) side of the industry. In 1994, he founded Advanced Biomedical Research, Inc, a full-service Phase I-IV CRO that focused on innovator compounds and complex studies. In 2009, he established Ready Clinical, LLC as a clinical and regulatory consultancy. Dr. Willett received his Bachelor and Doctor of Pharmacy degrees with honors from the University of Illinois and completed a residency in adult internal medicine at the University of Missouri-Kansas City and Truman Medical Center. For the past decade, he has maintained a US regulatory affairs certification from the Regulatory Affairs Professional Society.